Clinical trial
RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher…
NCT00263263 · Antwerp Cardiovascular Institute Middelheim, Other · Completed
Key facts
| NCT number | NCT00263263 |
|---|---|
| Title | RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent. |
| Official title | Phase 2 Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Degenerated Saphenous Vein Grafts |
| Lead sponsor | Antwerp Cardiovascular Institute Middelheim, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stable Angina, Unstable Angina, Coronary Artery Disease, Saphenous Vein Graft Disease |
| Intervention type | Device |
| Interventions | sirolimus-eluting stent, bare metal stent |
| Enrollment | 75 |
| Start date | Sep 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Dec 8, 2005 |
| Last update posted | Mar 14, 2007 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: